Skip to content
Jyothy Labs logo

Jyothy Labs

JYOTHYLAB NSE
₹188.13 −0.11 (−0.06%)
P/E
24.31
View as Markdown
MCP
Close 4 Nov 2026 ₹188.13 −125.32 −40.0% 1Y
Start ₹313.45

Key Fundamentals

MicrocapHousehold ProductsFMCG

Price-based figures as of · EPS basis: Standalone · TTM

ROCE
28.70%
Debt to Equity
0.03
EPS (TTM)
₹7.74
Book Value
₹43.26
Market Cap
—
P/E (TTM)
24.31
P/B
4.35
ROE
21.70%
Dividend Yield
1.86%
EBITDA
₹555 Cr
52W High
₹319.00
52W Low
₹171.00
Day Range
₹177.10 – ₹194.90
Volume
41,91,519

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

56 Good

Data confidence 100/100

Category scores

Quality
86
Strong
Returns, margins, earnings quality 22% weight
Valuation
49
Average
Cheap vs sector & own history 24% weight
Growth
41
Weak
Sales & profit trajectory 9% weight
Financial Health
88
Strong
Solvency, leverage, coverage 9% weight
Momentum
25
Poor
Trend strength, vol-adjusted 12% weight
Ownership
53
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

4
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 27.8%
  • Company has been maintaining a healthy dividend payout of 36.0%
  • Company's working capital requirements have reduced from 30.9 days to 14.9 days

Weaknesses

1
  • The company has delivered a poor sales growth of 9.33% over past five years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBearish865
OscillatorsBearish261
Moving AveragesStrong Bearish604

Key readings

RSI (14)
54.62
Neutral
MACD (12,26,9)
−2.48
Bullish
SMA (50)
191.23
Bearish
SMA (200)
214.55
Bearish

As of

Analyst Rating

Based on 10 analysts
BUY50%

5 of 10 analysts rate Buy, 2 Hold, 3 Sell.

As of

BUY
5
50%
HOLD
2
20%
SELL
3
30%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+6.68%
5Y+9.33%
3Y+5.86%
1Y+3.52%
TTM+3.92%

Net profit

Net profit growth by window
10Y+16.07%
5Y+11.88%
3Y+11.53%
1Y−10.24%
TTM−22.13%

Operating cash flow

Operating cash flow growth by window
10Y+7.77%
5Y+0.20%
3Y+7.79%
1Y+32.05%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+0.44 pp
5Y−1.53 pp
3Y+2.56 pp
1Y−2.29 pp
TTM−3.99 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹1,632 Cr
Mar 2018₹1,626 Cr
Mar 2019₹1,769 Cr
Mar 2020₹1,665 Cr
Mar 2021₹1,885 Cr
Mar 2022₹2,193 Cr
Mar 2023₹2,482 Cr
Mar 2024₹2,754 Cr
Mar 2025₹2,844 Cr
Mar 2026₹2,944 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹202 Cr
Mar 2018₹161 Cr
Mar 2019₹193 Cr
Mar 2020₹158 Cr
Mar 2021₹190 Cr
Mar 2022₹139 Cr
Mar 2023₹240 Cr
Mar 2024₹370 Cr
Mar 2025₹371 Cr
Mar 2026₹333 Cr

Analyst Forecasts

Forecast For
Sep 26 consensus · EBITDA
₹60.33 Cr −26.7% vs Jun 26
Reported High Mean Low

AI Analysis — Bull vs Bear

Generated 6 Jul 2026
AI opinion · based on fundamentals
Risk medium

Jyothy Labs is a nearly debt-free FMCG company with a market cap of ₹6,983 Cr trading at a PE of 21.2x. While it has delivered strong ROE averaging 26% over 10 years, recent performance shows deceleration with TTM sales growth at 4% and TTM profit declining 12%, and the stock has corrected 44% over the past year.

Bull Case 8
  • Company is virtually debt-free, providing financial flexibility and low interest burden in a rising rate environment
  • Consistent return on equity with 3-year ROE of 28% and 10-year average ROE of 26%, indicating efficient capital allocation
  • PE of 21.2x is relatively modest for an FMCG company compared to sector peers that often trade at 40-60x earnings
  • Healthy dividend payout ratio of 36% with a current dividend yield of 1.82%, offering income alongside potential capital appreciation
  • Working capital efficiency has improved significantly from 30.9 days to 14.9 days, freeing up cash for growth or shareholder returns
  • Compounded profit growth of 16% over 10 years demonstrates long-term earnings compounding ability
  • Price-to-book ratio of 4.44x is reasonable for a branded FMCG business with 26% long-term ROE, suggesting the stock is not excessively priced relative to its asset quality
  • 5-year compounded sales growth of 9% shows the company has been able to grow revenue through economic cycles including the pandemic period
Bear Case 8
  • Stock has declined 44% over the past 1 year, reflecting significant market concern about near-term fundamentals
  • TTM profit has declined 12%, reversing the trend of 14% compounded profit growth seen over 3 years
  • TTM sales growth has decelerated sharply to just 4%, well below the 5-year CAGR of 9% and 10-year CAGR of 7%
  • ROE has declined from 28% (3-year average) to 22% in the last year, indicating deteriorating profitability or rising equity base without proportional earnings growth
  • 5-year stock CAGR of only 2% and 10-year CAGR of just 3% show the company has delivered minimal long-term wealth creation for shareholders
  • 5-year compounded sales growth of 9.33% is considered poor for an FMCG company operating in a high-growth consumer market like India
  • 3-year stock CAGR of -7% indicates sustained underperformance even before the recent sharp correction
  • Market cap of ₹6,983 Cr makes Jyothy Labs a mid-cap FMCG player with limited pricing power compared to larger peers in categories like fabric care and dishwashing

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

121d ago

TL;DR: Jyothy Labs delivered modest 3.5% revenue growth to ₹2,944 crore in FY26 and maintained shareholder returns with a ₹3.50/share dividend. However, PAT declined to ₹333 crore, indicating margin compression that bears watching. The company is actively engaging investors and discussing brand license updates for PRIL and Fa. The trend is stable on the topline but profitability needs to recover for sentiment to turn decisively bullish.

Headwinds 1
  • PAT decline in FY26 Jun 19

    Profit after tax declined to ₹333 crore in FY26 despite revenue growth, signaling margin pressure in the FMCG business.

Positives 2
  • Final dividend of ₹3.50/share Jun 19

    Board recommended a final dividend of ₹3.50 per share for FY26, with record date June 29 and AGM on July 14, 2026.

  • Revenue up 3.5% to ₹2,944 crore Jun 19

    Jyothy Labs reported FY26 revenue of ₹2,944 crore, a 3.5% year-on-year increase reflecting steady topline growth.

Neutral 3
  • Investor meet with ICICI Prudential Jun 25

    One-on-one investor meeting scheduled with ICICI Prudential on June 29, 2026. No UPSI to be shared.

  • BRSR filed for FY26 Jun 19

    Business Responsibility & Sustainability Report for FY26 filed, detailing ESG initiatives and compliance metrics.

  • Record date fixed June 29 Jun 11

    June 29, 2026 set as record date for FY26 dividend eligibility. 35th AGM scheduled via video conferencing on July 14, 2026.

Quarterly Results

₹ Cr
JYOTHYLAB quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
686
732
677
659
741
733
704
666
751
736
740
717
773
Expenses
569
596
558
551
608
595
588
554
627
618
629
621
709
Operating Profit
118
135
119
108
134
138
116
112
124
118
111
97
65
OPM %
17%
18%
18%
16%
18%
19%
16%
17%
17%
16%
15%
13%
8%
Other Income
17
13
11
13
14
13
14
12
19
17
15
16
18
Interest
1
1
1
1
1
1
1
2
1
1
1
1
1
Depreciation
12
12
13
13
13
14
14
15
15
15
16
16
16
PBT
121
135
115
107
132
136
114
108
128
119
109
96
65
Tax %
21%
23%
21%
27%
23%
23%
23%
28%
24%
26%
26%
29%
27%
Net Profit
96
104
91
78
102
105
87
77
97
88
81
68
48
EPS (₹)
2.62
2.84
2.48
2.13
2.77
2.86
2.38
2.1
2.64
2.39
2.21
1.84
1.3

Profit & Loss

₹ Cr
JYOTHYLAB profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
1,438
1,542
1,632
1,626
1,769
1,665
1,885
2,193
2,482
2,754
2,844
2,944
2,966
Expenses
1,271
1,313
1,371
1,362
1,483
1,415
1,568
1,945
2,166
2,274
2,344
2,494
2,576
Operating Profit
166
229
261
264
286
250
317
248
316
480
500
450
390
OPM %
12%
15%
16%
16%
16%
15%
17%
11%
13%
17%
18%
15%
13%
Other Income
63
15
11
43
27
16
−4
18
47
54
51
67.56
66
Interest
12
56
51
42
28
25
12
12
13
5
6
5
5
Depreciation
70
54
55
57
58
76
78
89
50
50
56
61
63
PBT
147
133
166
208
228
166
223
166
299
479
490
451
389
Tax %
3%
44%
−22%
23%
15%
5%
15%
16%
20%
23%
24%
26%
—
Net Profit
143
75
202
161
193
158
190
139
240
370
371
333
284
EPS (₹)
3.94
2.06
5.56
4.42
5.26
4.29
5.18
3.78
6.52
10.07
10.11
9.07
7.74
Div. Payout %
51%
122%
54%
6%
57%
70%
77%
66%
46%
35%
35%
39%
—

Balance Sheet

₹ Cr
JYOTHYLAB balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
18
18
18
18
37
37
37
37
37
37
37
37
Reserves
944
454
635
665
817
707
897
696
845
1,105
1,346
1,552
Borrowings
519
402
451
479
217
221
97
171
47
51
61
52
Other Liabilities
436
460
255
297
341
325
393
448
464
540
580
612
Total Liabilities
1,916
1,334
1,360
1,459
1,412
1,289
1,424
1,352
1,392
1,732
2,024
2,252
Fixed Assets
570
538
542
489
471
484
457
440
435
444
460
504
CWIP
5
8
8
15
14
24
10
8
15
13
22
10
Investments
409
205
154
246
242
139
141
6
6
197
456
506
Other Assets
932
583
656
709
685
642
815
898
936
1,077
1,085
1,232
Total Assets
1,916
1,334
1,360
1,459
1,412
1,289
1,424
1,352
1,392
1,732
2,024
2,252

Cash Flow

₹ Cr
JYOTHYLAB cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
158
195
166
251
305
165
408
201
329
458
312
412
Investing
0
97
−20
−81
25
72
−149
−29
−48
−344
−161
−277
Financing
−54
−300
−127
−149
−316
−297
−196
−166
−251
−135
−157
−160
Net Cash Flow
103
−7
18
21
13
−60
63
6
30
−21
−7
−25
Free Cash Flow
153
172
110
257
267
126
384
180
317
444
254
346
CFO/OP
119
108
75
105
121
81
139
94
122
112
82
105

Ratios

JYOTHYLAB financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
13
21
25
35
31
26
17
23
19
26
35
32
Inventory Days
87
81
80
79
76
91
101
84
76
73
84
80
Days Payable
62
69
60
62
66
52
69
67
55
72
75
74
Cash Conversion Cycle
38
33
46
52
40
65
48
40
41
28
45
38
Working Capital Days
−33
−108
−77
−77
−20
−9
9
−3
12
39
39
15
ROCE %
11%
16%
22%
20%
23%
19%
26%
18%
31%
44%
37%
29%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Jyothy Labs insights

79 extracted metrics across FY00–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 62.89%
  • FIIs 14.48%
  • Public 10.58%
  • DIIs 9.86%
  • Others 2.18%
  • Government 0.01%

No promoter shares pledged as of Sep 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Jyothy Labs

What does Jyothy Labs Ltd do?
Jyothy Labs Limited was founded in 1983 by Mr. M. P. Ramachandran in Thrissur, Kerala. JLL is renowned brand in the domestic FMCG industry.It has a diversified product portfolio spanning four major categories of fabric care, dishwashing, household insecticides (HI) and personal care and an…
Where is Jyothy Labs Ltd (JYOTHYLAB) listed?
Jyothy Labs Ltd trades as JYOTHYLAB on the NSE and under code 532926 on the BSE.
Which sector does Jyothy Labs Ltd belong to?
Jyothy Labs Ltd is classified under the Consumer Goods sector, in the Household Products industry.
What is the PE ratio of Jyothy Labs Ltd?
Jyothy Labs Ltd trades at a PE ratio of 24.31 as of 4 Nov 2026, on earnings per share of ₹7.74, against a book value of ₹43.26 per share.
What is the 52-week high and low of Jyothy Labs Ltd?
Over the last 52 weeks Jyothy Labs Ltd has traded between ₹171 and ₹319 as of 4 Nov 2026.
Does Jyothy Labs Ltd pay dividends?
Jyothy Labs Ltd has a dividend yield of 1.86%.
What is the Return on Equity (ROE) of Jyothy Labs Ltd?
Jyothy Labs Ltd reported a return on equity of 21.70%. Its debt-to-equity ratio is 0.03.

Company Information

Jyothy Labs Limited was founded in 1983 by Mr. M. P. Ramachandran in Thrissur, Kerala. JLL is renowned brand in the domestic FMCG industry.It has a diversified product portfolio spanning four major categories of fabric care, dishwashing, household insecticides (HI) and personal care and an established market position in the post-wash (under Ujala brand) and the dishwashing segments (under Pril and Exo brands).

Website jyothylabs.com
CEO Ms. Moothedath Ramachandran Jyothy
Employees 3,035
Listed 19 Dec 2007
Face Value ₹1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/JYOTHYLAB.md for Jyothy Labs Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Household Products stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month